nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Kohl, Katrin S. |
|
2007 |
25 |
31 |
p. 5821-5838 18 p. |
artikel |
2 |
Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Rüggeberg, Jens U. |
|
2007 |
25 |
31 |
p. 5675-5684 10 p. |
artikel |
3 |
Aseptic meningitis: Case definition and guidelines for collection, analysis and presentation of immunization safety data
|
Tapiainen, Terhi |
|
2007 |
25 |
31 |
p. 5793-5802 10 p. |
artikel |
4 |
Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Halperin, Scott |
|
2007 |
25 |
31 |
p. 5803-5820 18 p. |
artikel |
5 |
Eczema vaccinatum as an adverse event following exposure to vaccinia virus: Case definition & guidelines of data collection, analysis, and presentation of immunization safety data
|
Nell, Patricia |
|
2007 |
25 |
31 |
p. 5725-5734 10 p. |
artikel |
6 |
Editorial Board
|
|
|
2007 |
25 |
31 |
p. CO2- 1 p. |
artikel |
7 |
Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2)
|
Voigt, Heiner |
|
2007 |
25 |
31 |
p. 5915-5926 12 p. |
artikel |
8 |
Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data
|
Sejvar, James J. |
|
2007 |
25 |
31 |
p. 5771-5792 22 p. |
artikel |
9 |
Fatigue: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Jones, James F. |
|
2007 |
25 |
31 |
p. 5685-5696 12 p. |
artikel |
10 |
Generalized vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Beigel, John |
|
2007 |
25 |
31 |
p. 5745-5753 9 p. |
artikel |
11 |
Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case–control study using the self-controlled case series method
|
Hocine, M.N. |
|
2007 |
25 |
31 |
p. 5938-5943 6 p. |
artikel |
12 |
Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: Case definition and guidelines for data collection, analysis, and presentation
|
Buettcher, Michael |
|
2007 |
25 |
31 |
p. 5875-5881 7 p. |
artikel |
13 |
Inadvertent inoculation as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Wenger, Peter |
|
2007 |
25 |
31 |
p. 5754-5762 9 p. |
artikel |
14 |
Induration at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Kohl, Katrin S. |
|
2007 |
25 |
31 |
p. 5839-5857 19 p. |
artikel |
15 |
Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection
|
Pancré, Véronique |
|
2007 |
25 |
31 |
p. 5927-5937 11 p. |
artikel |
16 |
Progressive vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data
|
Nell, Patricia |
|
2007 |
25 |
31 |
p. 5735-5744 10 p. |
artikel |
17 |
Rash including mucosal involvement: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Beigel, John |
|
2007 |
25 |
31 |
p. 5697-5706 10 p. |
artikel |
18 |
Robust take following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data
|
Graham, Philip L. |
|
2007 |
25 |
31 |
p. 5763-5770 8 p. |
artikel |
19 |
Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data
|
Kohl, Katrin S. |
|
2007 |
25 |
31 |
p. 5858-5874 17 p. |
artikel |
20 |
The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection
|
Toubaji, Antoun |
|
2007 |
25 |
31 |
p. 5882-5891 10 p. |
artikel |
21 |
The development of standardized case definitions and guidelines for adverse events following immunization
|
Kohl, Katrin S. |
|
2007 |
25 |
31 |
p. 5671-5674 4 p. |
artikel |
22 |
The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition
|
Hijnen, Marcel |
|
2007 |
25 |
31 |
p. 5902-5914 13 p. |
artikel |
23 |
Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Wise, Robert P. |
|
2007 |
25 |
31 |
p. 5717-5724 8 p. |
artikel |
24 |
Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Jorch, Gerhard |
|
2007 |
25 |
31 |
p. 5707-5716 10 p. |
artikel |
25 |
Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry
|
James, Cassandra M. |
|
2007 |
25 |
31 |
p. 5892-5901 10 p. |
artikel |